MALAT1 levels were also shown to be higher in lung cancer patients with BrM, and functional studies indicate that MALAT1 promotes migration and metastasis of brain-metastatic lung cancer cells by inducing EMT [135]. This evidence concerns the gene SMARCA2 and lung cancer.